Loading...

Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL £41
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  2. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  3. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  4. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  5. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  6. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  7. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  8. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  9. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  10. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  11. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  12. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  13. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  14. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  15. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  16. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  17. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  18. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  19. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  20. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  21. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  22. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  23. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  24. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  25. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  26. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  27. Chan L, et al. 2022. Cells. 12: . PubMed
  28. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  29. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  30. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  31. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  32. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  33. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  34. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  35. Zander R, et al. 2022. Immunity. 55:475. PubMed
  36. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  37. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  38. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  39. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  40. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  41. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  42. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  43. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  44. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  45. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  46. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  47. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  48. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  49. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  50. Wang H, et al. 2023. Nature. 615:339. PubMed
  51. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  52. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  53. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  54. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  55. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  56. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  57. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  58. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  59. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  60. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  61. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  62. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  63. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  64. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  65. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  66. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  67. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  68. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  69. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  70. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  71. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  72. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  73. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  74. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  75. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  76. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  77. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  78. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  79. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  80. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  81. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  82. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  83. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  84. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  85. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  86. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  87. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  88. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  89. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  90. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  91. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  92. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  93. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  94. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  95. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  96. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  97. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  98. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  99. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  100. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  101. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  102. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  103. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  104. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  105. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  106. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  107. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  108. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  109. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  110. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  111. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  112. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  113. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  114. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  115. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  116. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  117. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  118. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  119. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  120. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  121. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  122. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  123. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  124. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  125. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  126. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  127. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  128. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  129. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  130. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  131. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  132. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  133. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  134. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  135. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  136. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  137. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  138. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  139. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  140. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  141. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  142. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  143. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  144. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  145. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  146. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  147. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  148. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  149. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  150. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  151. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  152. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  153. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  154. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  155. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  156. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  157. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  158. Ma K, et al. 2022. iScience. 25:104347. PubMed
  159. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  160. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  161. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  162. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  163. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  164. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  165. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  166. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  167. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  168. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  169. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  170. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  171. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  172. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  173. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  174. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  175. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  176. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  177. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  178. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  179. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  180. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  181. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  182. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  183. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  184. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  185. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  186. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  187. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  188. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  189. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  190. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  191. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  192. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  193. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  194. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  195. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  196. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  197. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  198. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  199. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  200. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  201. Wang X, et al. 2022. Elife. 11:. PubMed
  202. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  203. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  204. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  205. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  206. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  207. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  208. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  209. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  210. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  211. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  212. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  213. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  214. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  215. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 4    Revision Date: 07/25/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account